Cancer News and Research

Latest Cancer News and Research

First artificial bronchus graft in a lung cancer patient successful

In a medical breakthrough French surgeons have grafted an artificial airway to save a lung afflicted by bronchial cancer in a 78-year-old man. The bronchi are the main tubes or airways used for taking air from the trachea to the two sides of the lung.

3 Mar 2011

Scientist receives $4 million Australia fellowship to continue cancer origin research

Walter and Eliza Hall Institute cancer researcher Professor Jane Visvader has received a $4 million fellowship from the Australian Government to continue her work into the origin of breast, ovarian and lung cancers.

3 Mar 2011

DNA methylation patterns can accurately detect early bowel cancer

Cancer Research UK scientists have discovered for the first time that DNA methylation patterns - a key process in cell development - could accurately detect early bowel cancer, according to research published in Gut, today.

3 Mar 2011

VICC introduces nation's first personalized cancer decision support tool

Vanderbilt-Ingram Cancer Center has launched the nation's first personalized cancer decision support tool, "My Cancer Genome," to help physicians and researchers track the latest developments in personalized cancer medicine and connect with clinical research trials for their patients.

3 Mar 2011

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo Pharmaceuticals announced that FORTESTA Gel – recently approved by the U.S. Food and Drug Administration for the treatment of low testosterone, or 'Low T' in adult males – is now available by prescription in pharmacies across the country.

3 Mar 2011

Scientists uncover genetic pathway that affects breast cancer development

Using recent advances in genomics, researchers have uncovered a genetic pathway that affects the development of breast cancer, work that could help predict which patients are at risk of relapse for the disease.

3 Mar 2011

Medical Oncology recognized at EU level to allow free movement of doctors

The European Society for Medical Oncology (ESMO), the leading professional organization for medical oncology in Europe, proudly announced that medical oncology has been included among the medical specialties covered by Directive 2005/36/EC on the recognition of professional qualifications, as announced today by the Commission. The decision was taken after several years of intense discussion between ESMO, key national societies and EU Member States.

3 Mar 2011

Rural women seek breast cancer screenings for the good of their families

A new study published in the Journal of Consumer Affairs finds that women from rural populations are motivated to seek breast cancer prevention screenings primarily out of concern for the long-term well being of their families. The study shows that by appealing to their strength as caretakers doctors can encourage their rural patients to perform breast health self-examinations, get mammograms, and to talk with doctors about their breast health.

3 Mar 2011

Genetics and cancer research

The 20th century was dominated by breakthroughs in physics and chemistry, but the 21st century will belong to genetics and biotechnology. Cancer research is just one area among many that is being transformed by the sequencing of the human genome. This was one of the topics discussed in our recent panel with leading cancer researchers, part of our Breakthroughs: Cancer series.

3 Mar 2011

EU's Avastin policy: A stark contrast to the FDA's recent decision

The committee's decision stands in stark contrast to the recent verdict by the U.S. Food and Drug Administration, which is wary of Avastin's benefits for breast-cancer patients.

3 Mar 2011

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Infinity Pharmaceuticals, Inc. today announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to placebo in patients with metastatic or locally advanced, inoperable chondrosarcoma. The trial is expected to enroll over 100 patients worldwide.

3 Mar 2011

Positive outcomes from Argos AGS-004 Phase 2a trial in patients with HIV

Argos Therapeutics announced today that its Arcelis immunotherapy for the treatment of HIV, AGS-004, demonstrated positive outcomes with the primary endpoint of viral load control and a favorable safety and immunogenicity profile in a final analysis of a Phase 2a clinical trial.

3 Mar 2011

Sarsia grants BerGenBio NOK7 million to continue CellSelect advanced technology platform

BerGenBio has secured NOK7 million from local Sarsia Seed and Development funds to continue its leading research and development activities into new and original cancer treatments.

3 Mar 2011

ContextVision launches MAMMO PlusViewCAD breast cancer detection tool at ECR

ContextVision is pleased to a announce that today at the ECR in Vienna, it is officially launching the first product stemming from its recently announced strategic alliance with NeuSoft Medical Technologies.

3 Mar 2011

Roche, OraSure receive FDA 510(k) clearance for Oral Fluid Drug Testing System

OraSure Technologies, Inc. and Roche announced today that the U.S. Food and Drug Administration has granted the Companies 510(k) clearance on four homogeneous fully automated oral fluid drugs of abuse assays developed to be used exclusively as part of OraSure's Intercept Oral Fluid Drug Testing System.

3 Mar 2011

New insight: p53 protein controls molecular crossroads in glucose metabolic pathway

The gene for the protein p53 is the most frequently mutated in human cancer. It encodes a tumor suppressor, and traditionally researchers have assumed that it acts primarily as a regulator of how genes are made into proteins.

3 Mar 2011

New discovery in glioma-associated metabolic changes

Metabolon, Inc., the leader in metabolomics, biomarker discovery and analysis, announces the publication of "Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome", in The Proceedings of the National Academy of Sciences.

3 Mar 2011